Metastatic Gastric Adenocarcinoma Terminated Phase 1 Trials for Indusatumab vedotin (DB12413)

Also known as: Adenocarcinoma gastric / Adenocarcinoma of stomach (disorder)

IndicationStatusPhase
DBCOND0074521 (Metastatic Gastric Adenocarcinoma)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02391038MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase CTreatment